1. Home
  2. Author
  3. Lang AE

Lang AE

References (3)

Title : Metabolic and vascular contributions to dementia: Soluble epoxide hydrolase-derived linoleic acid oxylipins and glycemic status are related to cerebral small vessel disease markers, atrophy, and cognitive performance - Ryoo_2025_Alzheimers.Dement_21_e70718
Author(s) : Ryoo SW , Lin WZ , Magliocco A , Ruthirakuhan M , Wong YY , Perfetto SE , Huang C , Anita NZ , Arnott SR , Lang AE , Symons S , Hegele RA , Goubran M , Ramirez J , Ottoy J , Rabin JS , MacIntosh BJ , Lanctot KL , Liang N , Cogo-Moreira H , Taha AY , Swardfager W
Ref : Alzheimers Dement , 21 :e70718 , 2025
Abstract :
PubMedSearch : Ryoo_2025_Alzheimers.Dement_21_e70718
PubMedID: 41059602

Title : Pimavanserin for Parkinson's Disease psychosis: Effects stratified by baseline cognition and use of cognitive-enhancing medications - Espay_2018_Mov.Disord_33_1769
Author(s) : Espay AJ , Guskey MT , Norton JC , Coate B , Vizcarra JA , Ballard C , Factor SA , Friedman JH , Lang AE , Larsen NJ , Andersson C , Fredericks D , Weintraub D
Ref : Movement Disorder , 33 :1769 , 2018
Abstract :
PubMedSearch : Espay_2018_Mov.Disord_33_1769
PubMedID: 30387904

Title : Pharmacological treatment of Parkinson disease: a review - Connolly_2014_JAMA_311_1670
Author(s) : Connolly BS , Lang AE
Ref : Jama , 311 :1670 , 2014
Abstract :
PubMedSearch : Connolly_2014_JAMA_311_1670
PubMedID: 24756517